Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

被引：0
|
作者：
François-Clément Bidard
David Hajage
Thomas Bachelot
Suzette Delaloge
Etienne Brain
Mario Campone
Paul Cottu
Philippe Beuzeboc
Emilie Rolland
Claire Mathiot
Jean-Yves Pierga
机构：
[1] Institut Curie,Department of Medical Oncology
[2] Université Paris Descartes,Department of Biostatistics
[3] Institut Curie,Department of Medical Oncology
[4] Centre Léon Bérard,Department of Medical Oncology
[5] Institut Gustave Roussy,Department of Medical Oncology
[6] Institut Curie,Department of Medical Oncology
[7] Hôpital René Huguenin,Hematology laboratory
[8] Institut de Cancérologie de l'Ouest,undefined
[9] Bd Monod,undefined
[10] Institut Curie,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Progression Free Survival; Metastatic Breast Cancer; Circulate Tumor Cell; Serum Marker; Metastatic Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients
    Benezeder, Theresa
    Tiran, Verena
    Treitler, Alexandra A. N.
    Suppan, Christoph
    Rossmann, Christopher
    Stoeger, Herbert
    Cote, Richard J.
    Datar, Ram H.
    Balic, Marija
    Dandachi, Nadia
    ONCOTARGET, 2017, 8 (54) : 92483 - 92496
  • [2] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [3] Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint
    Hurvitz, Sara A.
    CANCER TREATMENT REVIEWS, 2011, 37 (07) : 495 - 504
  • [4] Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
    Hurvitz, Sara A.
    Lalla, Deepa
    Crosby, Ross D.
    Mathias, Susan D.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 603 - 609
  • [5] Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
    Sara A. Hurvitz
    Deepa Lalla
    Ross D. Crosby
    Susan D. Mathias
    Breast Cancer Research and Treatment, 2013, 142 : 603 - 609
  • [6] Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
    Goldvaser, Hadar
    Ribnikar, Domen
    Fazelzad, Rouhi
    Seruga, Bostjan
    Templeton, Arnoud J.
    Ocana, Alberto
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2017, 59 : 46 - 53
  • [7] Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
    Mertz, Shirley
    Benjamin, Christine
    Girvalaki, Charis
    Cardone, Antonella
    Gono, Paulina
    May, Suepattra G.
    Comerford, Erin
    Than, Kyi-Sin
    Birch, Kelly
    Roach, Meaghan
    Myers, Sky
    Sasane, Medha
    Lavi, Liat
    Cameron, Anna
    Cardoso, Fatima
    BREAST, 2022, 65 : 84 - 90
  • [8] Estimating changes in overall survival using progression-free survival in metastatic breast and colorectal cancer
    Bowater, Russell J.
    Lilford, Philippa E.
    Lilford, Richard J.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (03) : 207 - 214
  • [9] Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial†
    Jiang, Z. F.
    Cristofanilli, M.
    Shao, Z. M.
    Tong, Z. S.
    Song, E. W.
    Wang, X. J.
    Liao, N.
    Hu, X. C.
    Liu, Y.
    Wang, Y.
    Zeng, L.
    Zhang, M.
    ANNALS OF ONCOLOGY, 2013, 24 (11) : 2766 - 2772
  • [10] The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis
    Dabush, Dor Reuven
    Shepshelovich, Daniel
    Shochat, Tzippy
    Tibau, Ariadna
    Amir, Eitan
    Goldvaser, Hadar
    CANCER TREATMENT REVIEWS, 2021, 100
12345